ACCRUFeR® (ferric maltol) is now available in Canada as a prescription oral treatment for iron deficiency anemia
Kye Pharmaceuticals, Inc. ("Kye") announced today that ACCRUFeR® (ferric maltol) is now available across Canada. ACCRUFeR® is ...
Mena FN1mon
Ferric Citrate Market To Reach USD 4.4 Billion By 2034, Growing At A CAGR Of 8.3% From 2025 To 2034
The growing prevalence of CKD globally is a major driver of this market, alongside its dual role in iron and phosphate ... and grow at a CAGR of 8.3% from 2025 to 2034. . Ferric Citrate Market ...